Clodronate: A Review of its Use in the Prevention of Bone Metastases and the Management of Skeletal Complications Associated with Bone Metastases in Patients with Breast Cancer

Author： Toni M. Dando   Lynda R. Wiseman  

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.21, Iss.14, 2004-01, pp. : 949-962

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ibandronic Acid: A Review of its Use in the Treatment of Bone Metastases of Breast Cancer

By McCormack Paul L.   Plosker Greg L.  

Drugs, Vol. 66, Iss. 5, 2006-01 ,pp. : 711-728

Adis International

Access to resources Recommend Favorite

Pharmacotherapy of bone metastases in breast cancer patients – an update

By Jacobs Carmel   Simos Demetrios   Addison Christina   Ibrahim Mohammed   Clemons Mark  

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 8, 2014-06 ,pp. : 1109-1118

Informa Healthcare

Access to resources Recommend Favorite

Zoledronic Acid: A Review of its Use in the Management of Bone Metastases of Malignancy

By Dhillon Sohita   Lyseng-Williamson Katherine A.  

Drugs, Vol. 68, Iss. 4, 2008-01 ,pp. : 507-534

Adis International

Access to resources Recommend Favorite

Zoledronic Acid: A Pharmacoeconomic Review of its Use in the Management of Bone Metastases

By McKeage Kate   Plosker Greg L.  

PharmacoEconomics, Vol. 26, Iss. 3, 2008-01 ,pp. : 251-268

Adis International

Access to resources Recommend Favorite

Zoledronic Acid: A Review of its Use in the Management of Bone Metastases and Hypercalcaemia of Malignancy

By Wellington K.   Goa K.L.  

Drugs, Vol. 63, Iss. 4, 2003-01 ,pp. : 417-437

Adis International

Access to resources Recommend Favorite